Compile Data Set for Download or QSAR
Report error Found 15 Enz. Inhib. hit(s) with all data for entry = 50034033
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355797(CHEMBL1911742)
Affinity DataIC50: 6.40nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355805(CHEMBL1911750)
Affinity DataIC50: 27nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355793(CHEMBL1911640)
Affinity DataIC50: 74nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355804(CHEMBL1911749)
Affinity DataIC50: 140nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355795(CHEMBL1911642)
Affinity DataIC50: 150nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355796(CHEMBL1911643)
Affinity DataIC50: 160nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355803(CHEMBL1911748)
Affinity DataIC50: 270nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355802(CHEMBL1911747)
Affinity DataIC50: 430nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355801(CHEMBL1911746)
Affinity DataIC50: 730nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355793(CHEMBL1911640)
Affinity DataIC50: 2.60E+3nMAssay Description:Antagonist activity at OX1R intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355805(CHEMBL1911750)
Affinity DataIC50: 3.00E+3nMAssay Description:Antagonist activity at OX1R intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355800(CHEMBL1911745)
Affinity DataIC50: 3.00E+3nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355799(CHEMBL1911744)
Affinity DataIC50: 4.70E+3nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355794(CHEMBL1911641)
Affinity DataIC50: 6.40E+3nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50355798(CHEMBL1911743)
Affinity DataIC50: 8.20E+3nMAssay Description:Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/20/2012
Entry Details Article
PubMed